GCTK
Price
$6.98
Change
-$0.44 (-5.93%)
Updated
Jul 28, 12:55 PM (EDT)
Capitalization
8.11M
INMD
Price
$14.57
Change
-$0.15 (-1.02%)
Updated
Jul 28, 02:39 PM (EDT)
Capitalization
1.82B
2 days until earnings call
Interact to see
Advertisement

GCTK vs INMD

Header iconGCTK vs INMD Comparison
Open Charts GCTK vs INMDBanner chart's image
GlucoTrack
Price$6.98
Change-$0.44 (-5.93%)
Volume$141
Capitalization8.11M
InMode
Price$14.57
Change-$0.15 (-1.02%)
Volume$200
Capitalization1.82B
GCTK vs INMD Comparison Chart in %
Loading...
GCTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GCTK vs. INMD commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCTK is a Hold and INMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (GCTK: $7.42 vs. INMD: $14.72)
Brand notoriety: GCTK and INMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GCTK: 6% vs. INMD: 59%
Market capitalization -- GCTK: $8.11M vs. INMD: $1.82B
GCTK [@Medical Specialties] is valued at $8.11M. INMD’s [@Medical Specialties] market capitalization is $1.82B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GCTK’s FA Score shows that 0 FA rating(s) are green whileINMD’s FA Score has 0 green FA rating(s).

  • GCTK’s FA Score: 0 green, 5 red.
  • INMD’s FA Score: 0 green, 5 red.
According to our system of comparison, INMD is a better buy in the long-term than GCTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GCTK’s TA Score shows that 5 TA indicator(s) are bullish while INMD’s TA Score has 5 bullish TA indicator(s).

  • GCTK’s TA Score: 5 bullish, 3 bearish.
  • INMD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GCTK is a better buy in the short-term than INMD.

Price Growth

GCTK (@Medical Specialties) experienced а +27.27% price change this week, while INMD (@Medical Specialties) price change was +5.94% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.92%. For the same industry, the average monthly price growth was +4.24%, and the average quarterly price growth was -2.32%.

Reported Earning Dates

GCTK is expected to report earnings on May 14, 2025.

INMD is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Medical Specialties (+1.92% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INMD($1.82B) has a higher market cap than GCTK($8.11M). INMD YTD gains are higher at: -11.856 vs. GCTK (-98.342). INMD has higher annual earnings (EBITDA): 196M vs. GCTK (-5.95M). INMD has more cash in the bank: 742M vs. GCTK (6.89M). GCTK has less debt than INMD: GCTK (184K) vs INMD (9.02M). INMD has higher revenues than GCTK: INMD (492M) vs GCTK (0).
GCTKINMDGCTK / INMD
Capitalization8.11M1.82B0%
EBITDA-5.95M196M-3%
Gain YTD-98.342-11.856829%
P/E RatioN/A9.13-
Revenue0492M-
Total Cash6.89M742M1%
Total Debt184K9.02M2%
FUNDAMENTALS RATINGS
GCTK vs INMD: Fundamental Ratings
GCTK
INMD
OUTLOOK RATING
1..100
9850
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
10040
PRICE GROWTH RATING
1..100
9562
P/E GROWTH RATING
1..100
10080
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INMD's Valuation (63) in the null industry is in the same range as GCTK (94). This means that INMD’s stock grew similarly to GCTK’s over the last 12 months.

INMD's Profit vs Risk Rating (98) in the null industry is in the same range as GCTK (100). This means that INMD’s stock grew similarly to GCTK’s over the last 12 months.

INMD's SMR Rating (40) in the null industry is somewhat better than the same rating for GCTK (100). This means that INMD’s stock grew somewhat faster than GCTK’s over the last 12 months.

INMD's Price Growth Rating (62) in the null industry is somewhat better than the same rating for GCTK (95). This means that INMD’s stock grew somewhat faster than GCTK’s over the last 12 months.

INMD's P/E Growth Rating (80) in the null industry is in the same range as GCTK (100). This means that INMD’s stock grew similarly to GCTK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GCTKINMD
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
74%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 26 days ago
78%
Bullish Trend 6 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 11 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
GCTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHFAX13.740.06
+0.44%
Diamond Hill Large Cap Concentrated Inv
CRIHX12.110.05
+0.41%
CRM Long/Short Opportunities Instl
RETSX91.160.34
+0.37%
Russell Inv Tax-Managed US Large Cap S
VMVFX16.830.04
+0.24%
Vanguard Global Minimum Volatility Inv
ARBNX14.100.02
+0.14%
Arbitrage I

GCTK and

Correlation & Price change

A.I.dvisor tells us that GCTK and SIBN have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GCTK and SIBN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GCTK
1D Price
Change %
GCTK100%
-10.49%
SIBN - GCTK
31%
Poorly correlated
-0.63%
QTRX - GCTK
30%
Poorly correlated
+6.17%
IMDX - GCTK
24%
Poorly correlated
-2.53%
INMD - GCTK
23%
Poorly correlated
+1.31%
PEN - GCTK
23%
Poorly correlated
+1.27%
More